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Abstract
Metabolomics coupled with heavy-atom isotope-labelled glucose has been used to probe
the metabolic pathways active in cultured bloodstream form trypomastigotes of Trypano-
soma brucei, a parasite responsible for human African trypanosomiasis. Glucose enters
many branches of metabolism beyond glycolysis, which has been widely held to be the sole
route of glucose metabolism. Whilst pyruvate is the major end-product of glucose catabo-
lism, its transamination product, alanine, is also produced in significant quantities. The oxi-
dative branch of the pentose phosphate pathway is operative, although the non-oxidative
branch is not. Ribose 5-phosphate generated through this pathway distributes widely into
nucleotide synthesis and other branches of metabolism. Acetate, derived from glucose, is
found associated with a range of acetylated amino acids and, to a lesser extent, fatty acids;
while labelled glycerol is found in many glycerophospholipids. Glucose also enters inositol
and several sugar nucleotides that serve as precursors to macromolecule biosynthesis. Al-
though a Krebs cycle is not operative, malate, fumarate and succinate, primarily labelled in
three carbons, were present, indicating an origin from phosphoenolpyruvate via
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oxaloacetate. Interestingly, the enzyme responsible for conversion of phosphoenolpyruvate
to oxaloacetate, phosphoenolpyruvate carboxykinase, was shown to be essential to the
bloodstream form trypanosomes, as demonstrated by the lethal phenotype induced by
RNAi-mediated downregulation of its expression. In addition, glucose derivatives enter py-
rimidine biosynthesis via oxaloacetate as a precursor to aspartate and orotate.
Author Summary
In this work we have followed the distribution of carbon derived from glucose in blood-
stream form trypanosomes, the causative agent of African trypanosomiasis, revealing it to
enter a diverse range of metabolites. The work involved using 13C-labelled glucose and fol-
lowing the fate of the labelled carbon with an LC-MS based metabolomics platform. Be-
yond glycolysis and the oxidative branch of the pentose phosphate pathway the label
entered lipid biosynthesis both through glycerol 3-phosphate and also acetate. Glucose de-
rived carbon also entered nucleotide synthesis through ribose and pyrimidine synthesis
through oxaloacetate-derived aspartate. Appreciable quantities of the carboxylic acids suc-
cinate and malate were identified, although labelling patterns indicate they are not TCA
cycle derived. Amino sugars and sugar nucleotides were also labelled as was inositol used
in protein modification but not in inositol phospholipid headgroup production. We con-
firm active and essential oxaloacetate production in bloodstream form trypanosomes and
show that phosphoenolpyruvate carboxykinase is essential to these parasites using RNA
interference. The amount of glucose entering these metabolites is minor compared to the
quantity that enters pyruvate excreted from the cell, but the observation that enzymes con-
tributing to the metabolism of glucose beyond glycolysis can be essential offers potential
new targets for chemotherapy against trypanosomiasis.
Introduction
Trypanosoma brucei is a protozoan parasite, sub-species of which are responsible for human
African trypanosomiasis (HAT) and animal African trypanosomiasis (Nagana) [1]. Current
treatments for HAT are inadequate, and new preventative and therapeutic options are urgently
required [2]. The parasite is transmitted between mammalian hosts by a tsetse fly vector. The
physiological environments of mammalian blood and the tsetse midgut diverge significantly,
and bloodstream form and insect form parasites reveal adaptive differences in biochemistry to
allow optimised survival in these environments [3,4].
T. brucei possess glycosomes, peroxisome-derived organelles that contain enzymes required
for glycolysis [5]. Within the tsetse fly, glucose is generally scarce with proline a key energy
source [6]. Procyclic form (PCF) trypanosomes preferentially use proline as a source of carbon
and energy [6,7,8], although in glucose-rich culture medium they preferentially utilize glucose
through glycolysis [7,8]. For many years it has been widely accepted that bloodstream form
(BSF) trypanosomes exhibit greatly reduced metabolic potential, where glycosomal glucose uti-
lization through glycolysis is the sole energy source [4,5,9,10]. Under aerobic conditions pyru-
vate was considered the sole end-product, with the redox balance maintained by a
mitochondrial alternative oxidase shunt acting to regenerate dihydroxyacetone phosphate
(DHAP) from glycerol 3-phosphate [11]. Under anaerobiosis, equal quantities of pyruvate and
glycerol are produced, where the reverse reaction of glycerol kinase (GK) generates glycerol
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from glycerol 3-phosphate [9]. Early studies on BSF trypanosomes isolated from rodents iden-
tified other secreted metabolites, including succinate, aspartate and alanine [12–14]. However,
the fact that these products were present in small amounts and that stumpy form trypano-
somes, a non-replicative form of the parasite pre-adapted for life in the tsetse fly [15,16], could
contaminate the slender BSF preparations, led to these observations being considered of limit-
ed relevance in formulating models of a simplified pathway for glucose catabolism in the slen-
der replicative form of T. brucei [9].
Evidence for a more diverse fate of glucose in BSF trypanosome metabolism has, however,
emerged. For example, NMR analysis of glucose metabolism [17,18] confirmed glycerol and py-
ruvate as the major end products of glycolysis, while also detecting significant amounts of ala-
nine. The conversion of pyruvate to alanine may even be essential to BSF trypanosomes, since it
was not possible to knockout the alanine aminotransferase (AAT) gene [19], although signifi-
cant reduction of its transcript by RNAi was possible [19]. An oxidative branch of the pentose
phosphate pathway (PPP) is operative [20], and 6-phosphogluconate dehydrogenase is essential
to these forms [21,22]. Glucose-derived ribose was also shown to be incorporated into cellular
nucleotides in BSF trypanosomes [23,24], and inositol derived from glucose is incorporated
into the glycosylphosphatidyl inositol anchors attached to the abundant variant surface glyco-
protein coat of these cells [25,26]. Recently it was shown that pyruvate dehydrogenase (PDH)
becomes essential if slender bloodstream forms are deprived of threonine as a source of acetate
[27]; in this situation PDH is needed to generate acetate from glucose metabolism.
The systematic application of reverse genetics to PCF trypanosomes combined with NMR
analyses of end products of metabolism has demonstrated the importance of succinate fermenta-
tion pathways in both the glycosome and mitochondrion, through a route independent of the
classical TCA cycle [28–30]. A glycosomal succinate shunt converts phosphoenolpyruvate (PEP)
produced in the cytosol to oxaloacetate using PEP carboxykinase (PEPCK) following glycosomal
reuptake. PEP can also be converted to pyruvate, which enters the mitochondrion to feed the
PDH complex for production of acetyl-CoA, which is converted by the mitochondrial acetate:suc-
cinate CoA-transferase (ASCT) and acetyl-CoA thioesterase (ACH) to produce acetate [30,31].
The advent of metabolomics technology [32–34] allows an unbiased analysis of metabolism
across diverse pathways in T. brucei. Stable-isotope labelling permits direct detection of active
metabolic pathways within a live cell system [35–39] and offers a direct route to follow the dis-
tribution of atoms from a precursor substrate through the metabolic network. We have previ-
ously applied the approach to PCF trypanosomes [38], and here extend the methodology to
make a comprehensive assessment of the distribution of glucose-derived carbon through the
BSF trypanosome.
Results
Extensive glucose utilization for anabolic processes in bloodstream form
T. brucei
BSF T. brucei were fed a 50:50 mixture of U-12C and U-13C-glucose as the major carbon source
for one hour and 24 hours. Glycolytic intermediates were rapidly labelled, as expected as a re-
sult of high flux through the glycolytic pathway [10], with complete (50%) labelling of the
major end-product, pyruvate. Significant labelling was observed in metabolites of many other
pathways, indicating extensive anabolic utilization of glucose. In total, over 150 metabolites
were detected with glucose-derived carbon labelling, including sugar phosphates, sugar nucleo-
tides, lipids and secondary metabolites derived from glycolytic intermediates and end-products
(S1 Table). Whilst excreted pyruvate accounts for the majority of catabolised glucose [10], glu-
cose-derived pyruvate also serves as a major source of alanine and acetyl-CoA within the cell.
Trypanosome Glucose Metabolism
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Furthermore, metabolism of glucose through the oxidative branch of the PPP provides ribose
5-phosphate, as evidenced by its being 50% U-13C-labelled, which in turn is utilized for nucleo-
tide biosynthesis. Of significant interest was the labelling of numerous carboxylic acids includ-
ing malate, fumarate and succinate, and extensive labelling in aspartate and various
pyrimidines. In all, these results demonstrate extensive utilization of glucose for anabolic pur-
poses in bloodstream form T. brucei (Fig 1).
Revisiting glycolysis in bloodstream form T. brucei
The glycolytic pathway is highly active in T. brucei, which explains the 6-carbon labelling in
glucose 6-phosphate (G6P), fructose 6-phosphate (F6P) and fructose-1,6-bisphosphate (FBP),
and the 3-carbon labelling in the triose phosphate intermediates of lower glycolysis (Fig 2).
Interestingly, additional 3-carbon labelled isotopologues of hexose phosphates were observed.
These isotopologues represent 10% of the intracellular G6P and F6P, and 40% of the FBP. These
metabolites were identified by exact mass and retention time using authentic standards, although
we cannot absolutely rule out other metabolites of the same mass and retention time (i.e. unan-
ticipated hexose phosphate isomers) co-eluting with these metabolites. These findings are incon-
sistent with unidirectional glucose flow through the Embden-Meyerhof-Parnas glycolytic
Fig 1. Overview of metabolites labelled from D-glucose in bloodstream form T. brucei.Metabolic network derived from detected metabolites and
annotated enzymes in T. brucei. Red nodes indicate labelled metabolites from 50%U-13C-glucose, with darker red indicating higher percentage labelling.
Grey nodes indicate no labelling detected. Nodes without spots indicate that the metabolite was not detected, but the presence is suggested by adjacent
metabolites in the network.
doi:10.1371/journal.ppat.1004689.g001
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pathway. Labelling studies with 100% U-13C-glucose produced very little 3-labelled hexose phos-
phate (~2% of the hexose phosphate is 3-labelled even when only ~97% of the glucose is labelled
inside the cells), indicating that all carbons in the hexose phosphates are originally derived from
glucose (Fig 2d). Considering this lack of another source and the absence of other reactions that
Fig 2. Labelling of glycolytic intermediates from 50%U-13C-glucose in BSF T. brucei. (A) Schematic of the glycolytic pathway in BSF T. brucei. Black
font = detected on LCMS, grey font = inferred intermediates not detected in this assay. (B) Heatmap of relative isotopologue abundances for glycolytic
intermediates after labelling for 24 hours with 50% U-13C-glucose in HMI11. 0 = all carbons unlabelled (e.g. U-12C-glucose), 6 = six carbons labelled (e.g.
U-13C-glucose). (C) Isotopologue abundances of hexose phosphates after labelling for 24 hours with 50% U-13C-glucose (n = 3, mean ± SD). (D)
Isotopologue abundances of glucose 6-phosphate after labelling for 24 hours with 100% U-12C-glucose (white columns), 50% U-13C-glucose (hatched
columns) or 100%U-13C-glucose (black columns) (n = 3, mean ± SD). Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; FBP, fructose-
1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; GA3P, glyceraldehyde 3-phosphate; 1,3BPG, 1,3-bisphosphoglycerate; 3PG, 3-phosphoglycerate;
2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate; G3P, glycerol 3-phosphate. Enzymes: 1, hexokinase; 2, glucose-6-phosphate isomerase; 3,
phosphofructokinase; 4, fructose-1,6-bisphosphatase; 5, aldolase; 6, triosephosphate isomerase; 7, glyceraldehyde 3-phosphate dehydrogenase; 8,
phosphoglycerate kinase; 9, phosphoglycerate mutase; 10, enolase; 11, pyruvate kinase; 12, alanine aminotransferase; 13, glycerol-3-phosphate
dehydrogenase; 14, glycerol kinase; 15, mitochondrial FAD-dependent glycerol-3-phosphate dehydrogenase; 16, methylglyoxal detoxification pathway.
doi:10.1371/journal.ppat.1004689.g002
Trypanosome Glucose Metabolism
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could produce 3-labelled hexose-phosphates, the 3-labelled hexose-phosphates most likely de-
rive from the 3-labelled fructose bisphosphate (possibly via the reverse phosphofructokinase re-
action although a contribution from fructose bisphosphatase cannot be ruled out).
Gluconeogenesis from amino acids or other carbon sources is not identified, consistent with pre-
vious observations [20].
The high percentage of 3-carbon labelled FBP when using the 50:50 mix of U-13C-glucose
and U-12C-glucose seems counter-intuitive, given the very strong net forward flux through gly-
colysis and the high concentration of FBP. However, our computational analysis shows that it
is not impossible. The aldolase reaction is reversible (the net aldolase flux = forward flux—
reverse flux). The observed labelling would require that the part of the FBP pool created by the
“reverse” aldolase reaction, working in the direction of FBP production, would represent 85%
(in HMI medium) or 97% (in CMMmedium) of the total FBP pool (see S1 Text for detailed ex-
planations). These large contributions by the reverse reaction are possible under certain condi-
tions, in spite of the net flux strongly favouring the forward direction. Simulations using a
previously published collection of models which are described in detail in [40] show that under
the classical assumption that glycosomes are impermeable, reverse aldolase fluxes can vary
widely with plausible kinetic parameter values, most frequently with between 0 and 60% of the
FBP pool coming from the “reverse” aldolase reaction (i.e. between 0 and 29% being potentially
3-labelled). However, if the glycosome is semi-permeable to metabolites smaller than FBP itself
(model 3 in ref 40) due to non-selective pore-forming channels in the glycosomal membrane
[41], high reverse aldolase flux, accounting for 60–99% of the FBP pool is favoured (S1 Text).
This would be in excellent agreement with the observed labelling pattern.
In addition to pyruvate, its transamination product alanine was produced, probably via
AAT, an enzyme previously shown to be essential to BSF trypanosomes [19]. Very low levels of
labelled lactate were also detected, with all three carbons labelled. No lactate dehydrogenase
has been identified in T. brucei, although L-lactate production has been shown to occur
through an unusual methylglyoxal detoxification pathway in trypanosomes [42], which may
correspond to the metabolite we find of the corresponding mass.
A number of potential pyruvate-derived conjugated metabolites were observed, although
their significance is unknown. For example, an abundant metabolite with either 3C or 6C label-
ling corresponding to the molecular formula C6H8O6, was putatively identified as parapyruvate
[43]. Pyruvate also appeared to form adducts with basic amino acids to produce metabolites
with mass, labelling and predicted retention times consistent with carboxyethyl-L-arginine and
carboxyethyl-L-ornithine (S1 Table). Another abundant novel 3-carbon labelled metabolite
was detected with a molecular formula of C6H9NO4S, a likely condensation product of pyru-
vate and cysteine, while C7H11NO5 may correspond to the formation of a pyruvate-threonine
adduct. These metabolites were more abundant in cells grown in HMI11 compared to CMM,
consistent with the greater abundance of L-cysteine and L-threonine in the richer medium. In
the absence of authentic standards, however, further analysis will be required to confirm the
structure and physiological relevance of these compounds.
Pentose phosphate pathway
The pentose phosphate pathway intermediates (6-phosphogluconate and ribose 5-phosphate)
are fully labelled, indicating a linear oxidative PPP derived from glucose 6-phosphate (Fig 3).
The complete (5-carbon) labelling of ribose in purine nucleotides confirms that this pathway is
the major source of ribose 5-phosphate for nucleotide synthesis (Fig 3e). This contrasts with
the situation in PCF T. brucei, which also possess an active non-oxidative branch of the PPP
[20] and show the characteristic 2-, 3- and 5-carbon ribose 5-phosphate labelling as a
Trypanosome Glucose Metabolism
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Fig 3. Labelling of pentose phosphate pathway and purine nucleotides from 50%U-13C-glucose in
BSF T. brucei. (A) PPP in BSF T. brucei. Black font = detected on LCMS, grey font = inferred intermediates
not detected in this assay. (B) Heatmap of relative isotopologue abundances for pentose phosphate pathway
intermediates after labelling for 24 hours with 50% U-13C-glucose in HMI11. (C) Representative mass spectra
for octulose 8-phosphate from T. brucei incubated with unlabelled (U-12C) glucose (top) and labelled (U-13C)
glucose (bottom). The +3, +5 and +8 isotopologues are predominant in the labelled sample. (D)
Chromatograms for all octulose 8-phosphate isotopologues from T. brucei incubated with unlabelled (U-12C)
glucose, labelled (U-13C) glucose, unlabelled (U-12C) ribose and labelled (U-13C) ribose. (n = 3). (E) Heatmap
of relative isotopologue abundances for purine nucleotides and cofactors after labelling for 24 hours with 50%
U-13C-glucose in HMI11. Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; 6PG, 6-
phosphogluconate; Ru5P, ribulose 5-phosphate; R5P, ribose 5-phosphate; O8P, octulose 8-phosphate;
N9P, nonulose 9-phosphate; GA3P, glyceraldehyde 3-phosphate. (F) The T. brucei transaldolase gene was
heterologously expressed in E. coli and the protein purified (left hand panel, with the crude E. coli extract on
the left and purified protein to the right). Purified transaldolase was shown to produce octulose 8-phosphate
when provided with ribose 5-phosphate and fructose 6-phosphate as acceptor and donor substrates
respectively (right hand panel). Enzymes: 1, Hexokinase; 2, glucose 6-phosphate isomerase; 17, glucose 6-
Trypanosome Glucose Metabolism
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consequence of the transaldolase and transketolase (TKT) reactions that combine fully labelled
and fully unlabelled precursors [38]. The lack of these isotopologues thus confirms the lack of
TKT in BSFs [20,44].
Two high molecular weight sugar phosphates, octulose 8-phosphate (O8P) and nonulose 9-
phosphate (N9P) were detected and putatively identified by accurate mass and predicted reten-
tion time (as authentic standards are not available). The labelling patterns (Fig 3c-d) indicate
production by transaldolase activity from a three carbon unit donated from an aldose donor to
either a pentose phosphate (to produce O8P) or hexose phosphate (to produce N9P). Interest-
ingly, BSF T. brucei have previously been shown to possess transaldolase activity [20], in spite
of the absence of TKT. The absence of 2C- and 6C- labelled O8P in BSFs, while they are present
in PCFs [38], indicates that a PPP intermediate is the precursor for this metabolite. We ex-
pressed and purified the gene encoding T. brucei transaldolase (Tb927.8.5600) in Escherichia
coli. When the enzyme was mixed with ribose 5-phosphate and F6P as substrates, mass spec-
trometry revealed that O8P was produced, confirming the ability of this enzyme to carry out
this reaction (Fig 3f). Moreover, cells were labelled with U-13C-ribose which resulted in exten-
sive labelling of ribose 5-phosphate (produced by ribokinase), and significant 5-carbon label-
ling in O8P (Fig 3d).
The detection of metabolites with formulas consistent with sedoheptulose 7-phosphate
(C7H15O10P) and erythrose 4-phosphate (C4H9O7P) was surprising in a cell without TKT activ-
ity. However, the 50% U-13C-glucose labelling reveals only the 3-carbon labelled isotopologue
of each, confirming that these are not products of TKT. Further investigation found that the
abundance of the C7H15O10P peak was very low in all samples, and the retention time of
C4H9O7P was inconsistent with the authentic standard for erythrose 4-phosphate. More work
is therefore required to elucidate the identity and source of these metabolites, and to confirm
that a non-canonical pathway involved in sugar phosphate remodelling exists in trypanosomes.
Nucleotide salvage
The lack of uniform labelling in purine bases, nucleosides and nucleotides confirms the re-
quirement for exogenous purine bases in trypanosomatids which lack purine biosynthetic
pathways (Fig 3e). However, glucose-derived ribose produces 5-carbon labelled purine nucleo-
tides, as purine salvage pathways are highly active [45]. Transporters for the efficient uptake of
purine nucleosides have been characterized, and guanosine and inosine appear to be the major
purine sources in in vitro culture, even in the presence of excess hypoxanthine [46]. These la-
belling data also confirm that nucleoside hydrolases [47] that form purine bases are the prima-
ry route for nucleotide salvage from imported nucleosides and that glucose-derived ribose
5-phosphate is added through purine phosphoribosyltransferase [48]. The almost complete la-
belling of the ribose moiety of adenosine nucleotides indicates minimal purine salvage from ex-
ogenous adenosine by adenosine kinase under our in vitro growth conditions, in spite of its
high activity in these cells [49].
Intracellular synthesis of various cofactors, including NAD+ and S-adenosyl methionine
(AdoMet), was also confirmed by incorporation of labelled ribose into the nucleotide subunits.
AdoMet is an important precursor in polyamine synthesis, resulting in production of
5’methylthioadenosine (MTA). The 5-carbon labelling in these two metabolites confirms that
the labelling is in the ribose moiety. However, the absence of labelling in methionine precludes
activity of a methionine salvage pathway as previously proposed [50]. Methionine uptake from
phosphate dehydrogenase; 18, 6-phosphogluconate dehydrogenase; 19, ribose 5-phosphate isomerase; 20,
ribokinase; 21, transaldolase.
doi:10.1371/journal.ppat.1004689.g003
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serum [51] apparently fulfils all methionine requirements of BSF parasites. The absence of la-
belling in α-ketomethylthiobutyrate (KMTB), the last intermediate in the methionine salvage
pathway, further confirms the lack of function in this proposed pathway. KMTB probably
arises instead from transamination of methionine, and it was previously shown to be excreted
from parasites along with other amino acid-derived keto acids [46].
Carboxylic acid derivatives of catabolised glucose
An active TCA cycle is reportedly not operative in BSF T. brucei, and the observation that<1%
of detected 2-oxoglutarate contains label from glucose corroborates this (S1 Table). A small
amount of acetyl-coA and oxaloacetate were, nevertheless, directed into citrate, as seen/ob-
served by the 2-, 3- and 5-carbon labelling in excess of the natural abundance of 13C by a total
of approximately 1% in cells grown in HMI11, and 5% in CMM-grown cells (S2 Table). The
relevance of this low level citrate production is not known. PCF T. brucei do not use the classi-
cal citrate—malate shuttle, instead utilizing a unique acetate shuttle to provide acetyl-CoA to
the cytosol [31].
Isotope analysis of intracellular metabolites from cells incubated with 50% U-13C-labelled
glucose reveals three-carbon labelled isotopologues of succinate and malate, representing 35%
(70% when corrected for 50% labelled glucose precursor) of the intracellular malate (Fig 4) and
26% of succinate (52% corrected). This labelling pattern is consistent with the production of
succinate via a succinate fermentation pathway. The first enzyme of this pathway, PEPCK, is
found in BSF trypanosomes, albeit at a lower level than PCF [52,53]. Although oxaloacetate is
not detectable on this analytical platform, the observation of the 3-carbon labelled isotopologue
in aspartate (a transamination product of oxaloacetate) supports the production of oxaloace-
tate from PEP. The total labelling in aspartate (62% corrected) is comparable to malate (70%
corrected), demonstrating that intracellular aspartate is primarily synthesized from glucose-de-
rived oxaloacetate, rather than being taken up from the surrounding medium, which contains
aspartate at 100 μM [46]. BSF trypanosomes failed to demonstrate appreciable aspartate trans-
port capability [54]. T. brucei encodes three separate isoforms of malate dehydrogenase
(MDH), localized to the mitochondrion, glycosomes and the cytosol, respectively [55]. The gly-
cosomal isoform is reportedly absent from the BSF, while the cytosolic isoform is present at
higher levels in BSF than procyclics [55]. Additionally a small amount of the mitochondrial iso-
form is reportedly present [55–57]. The succinate fermentation pathway therefore might in-
volve oxaloacetate produced in the glycosome via PEPCK which might re-enter the cytosol and
possibly the mitochondrion for further metabolism. Further work, systematically removing or
knocking down expression of different isoforms, followed by metabolic profiling, will be re-
quired to deconvolute the sources of these partially reduced products of glucose catabolism in
the BSF trypanosome.
Aspartate use in nucleotide biosynthesis
Oxaloacetate-derived aspartate is a key precursor in pyrimidine synthesis, being converted to
orotate via dihydroorotate. Dihydroorotate and orotate were detected with isotope enrichment
equivalent to aspartate, ~35% 3-labelled carbons (70% corrected), confirming de novo synthesis
of pyrimidines in this way. Uracil labelling was slightly lower (44% corrected), suggesting some
uptake of uracil from the medium. However, higher levels of 2-labelling in UMP and UDP sug-
gest that de novo synthesized orotate is the major source of pyrimidines under these conditions
(Fig 4). Labelling of uridine and cytidine nucleotides was not significantly different between
the two different culture media used in this study, HMI11 and CMM. However, significant dif-
ferences were observed in thymidine nucleotides. dTTP and dTMP abundance in CMM-grown
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Fig 4. Glucose-derived dicarboxylic acid and pyrimidine metabolic pathways in BSF T. brucei indicate
activity of PEPCK. (A) Metabolic pathways of dicarboxylic acid and pyrimidine synthesis in BSF T. brucei.
Red carbons in structures indicate the predominant 13C labelling. (B) Heatmap of relative isotopologue
abundances for dicarboxylic acid and pyrimidine intermediates after labelling for 24 hours with 50% U-13C-
glucose in HMI11. (C) Isotopologue abundances of dTTP after labelling for 0 (U), 1 (L1) and 24 (L24) hours
with 50% U-13C-glucose in HMI11 (H) or CMM (M) (n = 2–3, mean ± SD). Extensive de novo dTTP synthesis
was only observed in CMM (i.e. in the absence of exogenous thymidine). Abbreviation: PEP,
phosphoenolpyruvate; Pyr, pyruvate; OxAc, oxaloacetate; Mal, malate; Fum, fumarate; Succ, succinate; Asp,
Aspartate; AdSucc, adenylosuccinate; DHO, dihydroorotate; Oro, orotate; Ura, uracil; Urd, uridine; dUrd,
deoxyuridine; Tmd, thymidine. Enzymes: 11, pyruvate kinase; 22, malate dehydrogenase; 23, fumarase; 24,
NADH-dependent fumarate reductase); 25, aspartate aminotransferase; 26, adenylosuccinate synthase; 27,
adenylosuccinate lyase; 28, aspartate carbamoyltransferase and dihydroorotase; 29, dihydroorotate
dehydrogenase; 30, orotate phosphoribosyltransferase and orotidine 5-phosphate decarboxylase; 31,
nucleoside diphosphatase; 32, ribonucleoside-diphosphate reductase; 33, thymidylate kinase; 34,
thymidylate synthase; 35, thymidine kinase; 36, uracil phosphoribosyltransferase; 37, uridine phosphorylase;
38, nucleoside diphosphate kinase; 39, cytidine triphosphate synthase.
doi:10.1371/journal.ppat.1004689.g004
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cells was only half that observed for HMI11, which contains 20 μM added thymidine. The iso-
tope labelling patterns of dTTP and dTMP in CMMmatched those of UMP and the other py-
rimidine nucleotides, indicating complete synthesis from de novo synthesized pyrimidines by
thymidylate synthetase in thymidine-poor media [58,59]. dTMP and dTTP in HMI11-grown
cells were less than 10% labelled, confirming a preference for thymidine salvage by the action
of thymidine kinase when exogenous thymidine is available (Fig 4c).
Aspartate is also an important intermediate in the purine salvage pathway, in which the for-
mation of adenylosuccinate and release of fumarate results in nitrogen transfer from aspartate
to IMP, producing AMP. Adenylosuccinate was detected with 3-carbon labelling, which con-
firms the role of glucose-derived aspartate in the purine salvage pathway (Fig 3e).
PEPCK is essential to BSF T. brucei
The discovery that glucose enters amino acid and nucleotide pathways via oxaloacetate indi-
cates that PEPCK might play an unexpectedly important role in BSF trypanosomes. Indeed, a
genome-wide RNAi screen indicated the gene could be essential [60]. To test this further, west-
ern blot analysis was performed with anti-PEPCK immune serum, showing that PEPCK is ex-
pressed in the BSF, albeit at much lower abundance than in the PCF (Fig 5). Two cell lines
(RNAiPEPCK-B3 and RNAiPEPCK-D6) were then generated to investigate the role of PEPCK in
BSF T. brucei by RNAi down-regulation of pepck gene expression. Both cell lines showed a
growth arrest two days after tetracycline induction. A phenotypic reversion 5 days post-induc-
tion correlated with a re-expression of PEPCK (Fig 5).
RNAiPEPCK labelled metabolomics
In order to measure the metabolic role of PEPCK, the production of succinate from glucose in
BSF trypanosomes was measured using 1H-NMR, as previously described for PCF T. brucei
[61]. The parental BSF 427 strain was incubated for 5 hours in PBS/NaHCO3 medium contain-
ing 4 mMD-glucose as the only carbon source and the incubation medium was analyzed by
1H-NMR spectroscopy. In addition to pyruvate, detectable amounts of succinate were quanti-
tatively measured, at levels ~2.7% of the excreted pyruvate (Fig 6a and Table 1). The amount of
excreted succinate was decreased 4.3 fold in the RNAiPEPCK-B3 mutant after two days of in-
duction compared to the wild-type cells (47 ±17 versus 201 ±89 nmol/h/mg of protein). Succi-
nate secretion increased five days after induction (79 ±18 nmol/h/mg of protein) (Fig 6a and
Table 1), as a consequence of pepck re-expression (Fig 5).
To confirm reduction of succinate production in the RNAiPEPCK-B3 tetracycline-induced
cell line (at 2 days), we determined incorporation of 13C-labelling from U-13C-glucose into in-
tracellular metabolites by LC-MS. A reduction of 13C3 incorporation into malate (24 ± 10%)
and succinate (29 ± 2%) was observed in the induced RNAiPEPCK-B3 cell line compared to the
non-induced cells (Fig 6b). Labelling in other products of PEPCK-derived oxaloacetate was
also significantly reduced, including aspartate (15-fold), uracil (3-fold) and UTP (2-fold). In
contrast, 13C incorporation into metabolites produced upstream of the PEPCK step (G6P, 3PG
and pyruvate), and those in other pathways derived from glycolytic intermediates (alanine, ace-
tyl-CoA, and ribose 5-phosphate) were not significantly altered (Fig 6b).
Acetate production in BSF T. brucei
In addition to its secretion and conversion to alanine, pyruvate is a major source of acetyl-CoA
in BSF trypanosomes. Although the intracellular concentration of acetyl-CoA was below the
limit of detection for our analytical method, evidence of its production is provided by 2-hydro-
xyethyl thiamine pyrophosphate (Fig 7a), the intermediate in pyruvate’s conversion to
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acetyl-CoA by PDH. The presence of two labelled carbons indicates formation directly from
glucose-derived pyruvate. Labelling was minimal after one hour, but complete labelling was ob-
served at 24 hours, suggesting that flux through this pathway is significantly slower than
through most other pathways (Fig 7a). It has recently been shown [27] that PDH knockdown
is conditionally lethal in BSF T. brucei. Both threonine, via a threonine dehydrogenase (TDH)
pathway, and glucose, via PDH, can provide acetate and the latter route becomes essential
when threonine is absent, or redundant due to loss of TDH [27]. Furthermore, acetylated me-
tabolites including acetylcarnitine, acetyllysine, acetylornithine and acetylglutamine were all
detected with 2 labelled carbons from glucose (S1 Table). The unlabelled proportion of these
metabolites probably relates to threonine’s key role in acetate provision [27].
Fig 5. PEPCK is essential to bloodstream form T. brucei. (A) Growth curve of two different clones showing down-regulation of pepck by RNAi
(RNAiPEPCK-D6 and RNAiPEPCK-B3) and the parental 427 BSF strain (WT) incubated in the presence (.i) or in the absence (.ni) of 10 μg/ml tetracycline.
Cells were maintained in the exponential growth phase (between 105 and 2x106 cells/ml) and cumulative cell numbers have been normalized for dilution
during cultivation. (B) Western blot analyses of the parental (WT) and mutant cell lines with the anti-PEPCK and anti-enolase sera containing antibodies as
indicated in the left margin. (C) Western blot demonstrates significantly higher levels of PEPCK in procyclic form (PF) compared to bloodstream form (BF) WT
T. brucei. *Analyses were performed on 5 x 106 cells per sample and HSP-60 is shown as the loading control.
doi:10.1371/journal.ppat.1004689.g005
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Glucose contributions to fatty acid and lipid biosynthesis
De novo fatty acid synthesis was detected in BSF T. brucei by incorporation of two labelled car-
bon units in free fatty acids and phospholipids (Fig 7b). However, the very low level of labelling
in fatty acids suggests that de novo fatty acid synthesis is minor compared to salvage
Fig 6. Metabolic profile of RNAiPEPCK-B3 BSF T. brucei confirms depletion of dicarboxylic acids and
pyrimidines. (A) Proton (1H) NMR analysis of excreted pyruvate and succinate from glucose. Pyruvate (Pyr)
and succinate (Suc) excreted by the bloodstream form 427 cell line (WT), and the RNAiPEPCK-B3 mutant
non-induced (ni), tetracycline-induced 2 days (i 2 days), and tetracycline-induced 5 days (i 5 days) was
determined by 1H-NMR. The cells were incubated in PBS containing 4 mM glucose for 4 hours. Each
spectrum corresponds to one representative experiment from a set of at least 3. A part of each spectrum
ranging from 2.2 ppm to 2.4 ppm is shown. (B) LC-MS analysis of intracellular glycolytic intermediates.
Relative isotopologue abundances following incubation in PBS containing 4 mMU-13C-glucose for 4 hours
for metabolic intermediates from RNAiPEPCK-B3 mutant non-induced (NI) and tetracycline-induced for 2 days
(I). Significant decreases in labelling were observed for PEPCK-derived metabolites including 3-carbon
labelling in dicarboxylic acids and aspartate, and 2-carbon labelling in pyrimidine nucleotides (or 7-carbon
labelling for ribose-containing metabolites). Labelling was not significantly decreased in glycolytic
intermediates or in other glucose-derived metabolites, including alanine, acetate (shown here as acetyllysine)
and ribose (shown here as 5-carbon labelling in UTP).
doi:10.1371/journal.ppat.1004689.g006
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mechanisms, and a high level of lysophospholipid uptake may represent the principal source of
fatty acids in these cells [62] with elongation accounting for modelling fatty acids of different
chain length [63].
The additional 3-carbon labelling observed in glycerophospholipids demonstrates that lipid
salvage utilizes glycolysis-derived glycerol 3-phosphate for synthesis of phospholipid head-
groups. Despite the requirement for salvage of host (or culture medium) lipids for the provi-
sion of choline, and most fatty acids, around half of the glycerol phosphate in lipid head-groups
was derived from glycolysis (ranging from 8 to 100% corrected labelling for detected PC (phos-
phatidylcholine) and PE (phosphatidylethanolamine) lipids; Fig 7 and S1 Table, the variability
relating to the fact that the relative contributions of the salvage and de novo synthesis pathways
are not uniform across lipid species.
Nucleotide sugars and glycoconjugate precursors
Several other labelled metabolites were detected (S1 Table) indicating that glucose enters
amino sugars (N-acetyl-D-glucosamine and N-acetyl-D-glucosamine 6-P), sugar nucleotides
(UDP-Glc, or UDP-Gal GDP-man and UDP-GlcNAC; Fig 7c) and low-level labelling in other
sugars (tentatively identified as myo-inositol, fructose, glucuronate and arabinonate, although
accurate identification of sugars is difficult using accurate mass-based metabolomics, as many
isomers are theoretically possible for most carbohydrate metabolites; hence, additional orthog-
onal approaches are required to confidently identify these structures. Nothwithstanding their
abundance is clearly low compared to glucose and fructose the two primary hexoses. Mannose
is absent in its free form, its generation occurring only when nucleotide conjugated and in
phosphorylated form [24]). Targeted studies of sugar nucleotide biosynthesis have already
demonstrated de novo biosynthesis of UDP-Glc [64] and GDP-Man [24] from glucose, and
analysis of inositol metabolism demonstrated de novo synthesis of inositol for protein glycosyl-
ation, in addition to inositol salvage for lipid biosynthesis [25,26]. Data from the current study
demonstrated less than 10% labelling in inositol, and confirmed that the inositol moiety of the
lipid headgroup glycerol-phosphoinositol was unlabelled (i.e. not formed by de novo synthesis
from glucose, consistent with targeted analyses conducted elsewhere to investigate the origin of
inositol in T. brucei [25,26]).
Discussion
The introduction of metabolomic technologies, particularly in conjunction with stable isotope
tracing has, in recent years, transformed our ability to analyse metabolism in biological
Table 1. Production of succinate, pyruvate, alanine and acetate from glucose in PEPCK RNAi T. brucei measured by 1H-NMR.
Cell line n Excreted molecules from glucose
Pyruvate Succinate Alanine Acetate
nmol / h / mg of protein
WTa 3 7534±1535 201±89 821±174 564±42
RNAiPEPCK-3.nib 6 7281±634 127±26 754±49 328±51
RNAiPEPCK-B3.ic 2days 7 6913±760 47±17 731±8 361±18
RNAiPEPCK-B3.ic 5days 3 6880±797 79±18 722±64 281±44
a Strain 427 bloodstream-form T. brucei
b Non-induced RNAiPEPCK-B3 (without added tetracycline)
c Induced RNAiPEPCK-B3 (with added tetracycline)
doi:10.1371/journal.ppat.1004689.t001
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Fig 7. Glucose is a carbon source for acetate, lipids and sugar nucleotides in WT BSF T. brucei. (A)
Time-dependent incorporation of glucose into diverse pathways. Relative isotopologue abundances for
unlabelled cells (0) and cells incubated with 50% U-13C-glucose in HMI11 for one hour (1) and 24 hours (24).
Labelling reaches equilibrium within 1 hour for pyruvate, alanine, malate, aspartate and ribose 5-phosphate.
Minimal labelling is observed in 2-hydroxyethyl-TPP after 1 hour, but complete (50%) labelling occurs within
24 hours, indicating a relatively slow flux towards acetate production by this pathway. (n = 3, mean ± SD). (B)
Heatmap of relative isotopologue abundances for lipids after labelling for 24 hours with 50%U-13C-glucose in
HMI11 indicating a combination of salvage mechanisms with de novo synthesized glycerol phosphate and
limited incorporation of glucose-derived acetyl-CoA. After manual curation, no isotopologues containing more
than 6 labelled carbons could be confirmed for the detected lipids. (C) Isotopologue abundances of UDP-N-
acetyl glucosamine (UDP-GlcNAc) after labelling for 24 hours with 50% U-13C-glucose in HMI11 reveal
incorporation of labelled carbon through glucosamine, acetate, ribose and uracil. Structures represent the
likely isotopologue(s) for each mass with 13C atoms and bonds shown in red. Additional minor isotopologues
have been omitted for clarity, the most abundant of which are isotopologues containing 3-labelled
glucosamine 6-phosphate.
doi:10.1371/journal.ppat.1004689.g007
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systems. For example, isotopologue studies into Leishmania [65], Plasmodium [36,37] and
Toxoplasma [35] have identified novel pathways and resolved long-standing questions of me-
tabolism. The African trypanosome, Trypanosoma brucei, is the causative agent of human Afri-
can trypanosomiasis, a neglected tropical disease of sub-Saharan Africa, for which new drugs
are urgently needed. The slender bloodstream form of these parasites has generally been con-
sidered to have a highly streamlined glucose catabolic pathway [3–5,9,10]. The localization of
the first seven enzymes of the glycolytic pathway to membrane-bounded peroxisome-like or-
ganelles known as glycosomes [5] has been proposed to be instrumental to the regulation of
flux through glycolysis by providing an environment in which ATP/ADP and NAD/NADH
can be balanced [9,10]. This arrangement has enabled the production of a well-defined dynam-
ic mathematical model of glycolysis [9,10] and the models have been able to predict several im-
portant phenomena, such as the contribution of different enzymes to the overall control of the
pathway. Recent iterations have included the addition of parameters that explicitly take into ac-
count uncertainty related to the system [66] and also the activity of the pentose phosphate
pathway [22] and the presence of permeability pores that allow free diffusion of several glyco-
lytic intermediates between the cytosol and glycosome [40].
Here we have taken the systematic route to analyse the full extent of glucose metabolism in
long slender BSF trypanosomes.
Extensive pyruvate production was observed, consistent with existing models of glycolytic
flux for energy production. However, the 3-carbon labelled isotopologues observed in glycolyt-
ic hexose phosphates reveals previously unreported complexity in this pathway. The lack of
transketolase [20,42] indicates that a canonical non-oxidative pentose phosphate cycle is miss-
ing from these cells and thus is not the source of 3-labelled hexose phosphates. The role of
transaldolase in BSFs is uncertain, and transaldolase-mediated production of 3-labelled fruc-
tose 6-phosphate (from F6P and GA3P) could be hypothesized, although this appears to be a
redundant reaction. Alternatively, aldolase [67], acting to combine either U-13C or U-12C
DHAP with U-13C or U-12C GA3P would produce the relative proportions of 0-, 3- and 6-
labelled fructose bisphosphate as identified here. The further production of 3-labelled F6P (and
G6P) from FBP would require fructose-1,6-bisphosphatase activity, and both transcriptomic
[68] and proteomic [69] data indicate that this enzyme is present in BSF T. brucei. A family of
models, simulating flux through glycolysis whilst taking into account our uncertainties about
the system and its distribution between glycosome and cytosol [40], reveals that if metabolites
smaller than FBP are able to exchange between compartments while FBP is not, then a signifi-
cant proportion of the total FBP in the cell can indeed arise through the condensation of GA3P
and DHAP. The data, therefore, supports the proposed role of pores creating a semi-permeable
glycosome [41]. Further work is required to fully investigate the intermediate fluxes in glycolyt-
ic metabolism and to determine the temporal and spatial aspects of metabolism that give rise to
these unexpected observations.
At this point we cannot rule out definitively the production of a compound with the mass
and retention time of FBP as an artefact of the experimental system. The same might be true of
other exotic, unexpected species identified in this study. However, a non-enzymatic aldol con-
densation of triose phosphates is highly unlikely, given that non-enzymatic condensations and
additions generally require extreme pH conditions (<1 or> 9). To confirm this, DHAP and
GA3P were mixed in CMMmedium followed by extraction in the conditions used to extract
our cellular lysates and storage for seven days at -80°C, and no FBP or other potential conden-
sation or addition products were observed by LC-MS. We therefore consider it likely that
many of the metabolites that we describe here are bona fide products of trypanosome metabo-
lism, and the incorporation of carbon-13 label confirms the endogenous production of these
metabolites (compared to the unlabelled metabolites primarily acquired from the serum in the
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growth media), although their physiological function, or indeed relevance remains unknown.
Metabolites can be produced either enzymatically or chemically in cells as inevitable by-prod-
ucts of metabolism, methylglyoxal being an example already discussed here [42].
Apart from the identification of numerous unexpected metabolites and pathways operat-
ing in BSF trypanosomes, our experiments also rule out the operation of other pathways pre-
viously assumed to be functional. For example, a rapid deamination of aromatic amino acids
was believed to contribute to a methionine cycle involved in provision of decarboxylated
S-adenosylmethionine used in polyamine synthesis [50]. Here, however, we demonstrate
that carbons from glucose do not enter methionine, which is provided exclusively through
cellular uptake instead [51]. This means that the pathways of methylthioadenosine detoxifi-
cation remain to be elucidated in the BSF trypanosome.
While the majority of glucose flows to secreted pyruvate under aerobic culture conditions,
we show that glucose metabolism is pervasive in the BSF parasites. In addition to pyruvate and
glycerol, various other metabolites are secreted, including alanine, the transaminated product
of pyruvate. This reaction appears to be essential since the alanine transaminase gene could not
be knocked out of the T. brucei genome [19], although knockdown by RNAi was possible. Suc-
cinate was also secreted. The succinate produced in BSF trypanosomes is primarily labelled in
three carbons, which indicates its derivation from glycolytic phosphoenolpyruvate, rather than
from a canonical TCA cycle, which would produce primarily 2-carbon and 4-carbon labelled
isotopologues. Analysis of the phosphoproteome of BSFs identified glycosomal NADH-depen-
dent fumarate dehydrogenase [70]. However, it is not possible to distinguish between glycoso-
mal, cytosolic or potentially mitochondrial derivation of these metabolites, and systematic
metabolite profiling following gene knockout or knockdown of various enzymes will be neces-
sary to deconvolute these pathways.
Although it has been suggested that glucose makes negligible contribution to anabolic pro-
cesses in BSF trypanosomes [10], numerous isolated studies have revealed that glucose serves
as a precursor in processes including sugar nucleotide and glycoconjugate synthesis [23], inosi-
tol production [25,26] and recently acetate production [27]. Glucose also enters pyrimidine
biosynthesis via oxaloacetate and lipid metabolism via glycerol 3-phosphate as well as acetate
production. RNAi knockdown of PEPCK confirmed this activity as being essential in BSF try-
panosomes. The same enzyme was not essential to PCFs, although its contribution is major in
this parasitic insect form [71]. We recently demonstrated that loss of bound phosphate from
the glycolytic pathway in the glycosome via the PPP requires a mechanism to retain the bound
phosphate balance [22]. PEPCK offers an obvious means to restore glycosomal ATP, and this
link to the PPP might explain the unexpectedly essential nature of this enzyme to the
BSF trypanosome.
Although the untargeted mass spectrometry platform we use here is intrinsically unable to
quantify the total flux of glucose carbon into the various pathways discussed here, it is clearly
the case that the overwhelming majority of glucose is catabolised to pyruvate (Table 1). The
total amount glucose entering these other pathways would be in the order of just a few percent
of the total consumed, in agreement with the measurements of Haanstra et al [10]. Although
only a small minority of the total glucose consumption, however, glucose is the major carbon
source for the production of many of these extra-glycolytic metabolites, and this flux is clearly
important given the fact that several enzymes, including PEPCK shown here, turn out to be es-
sential to the metabolism of these parasites.
The identification of novel essential enzymes in the BSF trypanosome may have important
implications for chemotherapy. Glycolysis has long been considered an attractive target given the
absolute dependency on glucose for energy and carbon provision to these cells [72]; our results
show that additional pathways around the periphery of glycolysis might be equally promising.
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Materials and Methods
Parasite culture
T. brucei brucei bloodstream form (s427) was cultured in vitro in HMI11 [73] and CMM [44]
supplemented with 10% fetal calf serum (FCS) Gold (PAA, Piscataway, NJ) at 37°C, 5% CO2.
Initial 5 ml cultures in 25 ml vented flasks (Corning) were grown to a maximum density of
4 × 106 cells/ml and subcultured by 1-in-100 or 1-in-1,000 dilution every 2 or 3 days, respec-
tively. A hemocytometer (Neubauer) was used for cell counts.
Labelling experiments and sample preparation
Two days prior to the extraction, 2 × 104 cells/ml were seeded in 30 ml of HMI11 and CMM.
Growth media was then replaced with media containing 50% of 13C-labelled glucose (12.5 mM
of 12C-glucose + 12.5 mM of 13C-glucose for HMI11, and 5 mM of 12C-glucose and 5 mM of
13C-glucose for CMM culture) at 24 h and 1 h prior to extraction. All samples were extracted at
the same time atequivalent cell densities of approximately 2 ×106 cells/ml. To yield 5 ×107 cells,
appropriate volumes of cell culture were harvested and quenched in EtOH/dry ice bath as pre-
viously described [74]. Cells were centrifuged at 1250 ×g for 10 min and spent media removed;
cells were washed with pre-cooled phosphate buffered saline (PBS) at 4°C. After centrifugation
at 1250 ×g for 5 min, the supernatant was removed and metabolites extracted by adding 100 μl
of (ice cold) chloroform/methanol/water (1:3:1) and mixed vigorously for 1 h at 4°C. The ex-
traction mixtures were centrifuged at 13,000 ×g for 10 min and the supernatants collected and
stored at -80°C prior to analysis. In order to assess instrument performance, one pooled quality
control (QC) sample was prepared by mixing an equal volume of all the samples. Independent
biological replicates were prepared on different days.
LC-MSmethodologies
Hydrophilic interaction liquid chromatography (HILIC) was carried out on a Dionex UltiMate
3000 RSLC system (Thermo Fisher Scientific, Hemel Hempstead, UK) using a ZIC-pHILIC
column (150 mm × 4.6 mm, 5 μm column, Merck Sequant) as previously described [74]. Brief-
ly, the column was maintained at 30°C and samples were eluted with a linear gradient (20 mM
ammonium carbonate in water, A and acetonitrile, B) over 46 min at a flow rate of 0.3 ml/min
as follows: 80% B to 20% B at 30 min, to 5% B at 32 min and held to 39 min for washing, to
80% B at 40 min and held to 46 min for re-equilibration. The injection volume was 10 μl and
samples were maintained at 4°C prior to injection. For the MS analysis, a Thermo Orbitrap
Exactive (Thermo Fisher Scientific) was operated in polarity switching mode and the MS set-
tings were as follows: resolution 50,000, AGC 106, m/z range 70–1400, sheath gas 40, auxiliary
gas 5, sweep gas 1, probe temperature 150°C, and capillary temperature 275°C. For positive
mode ionisation: source voltage +4.5 kV, capillary voltage +50 V, tube voltage +70 kV, skim-
mer voltage +20 V. For negative mode ionisation: source voltage-3.5 kV, capillary voltage-50
V, tube voltage-70 V, skimmer voltage-20 V. Mass calibration was performed for each polarity
immediately prior to each analysis batch. The calibration mass range was extended to cover
small metabolites by inclusion of low-mass contaminants with the standard Thermo calmix
masses (belowm/z 1400), C2H6NO2 for positive ion electrospray ionisation (PIESI) mode
(m/z 76.0393) and C3H5O3 for negative ion electospray ionisation (NIESI) mode (m/z
89.0244). To enhance calibration stability, lock-mass correction was also applied to each ana-
lytical run using these ubiquitous low-mass contaminants.
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Data processing and analysis
Raw LC-MS data were processed with XCMS for untargeted peak detection [75], and
mzMatch.R [76] was employed for peak matching and annotation of related peaks. Tentative
metabolite identification was carried out by IDEOM using the default parameters [77]. Metab-
olite identification was performed by matching accurate masses and retention times of authen-
tic standards (MSI confidence level 1, i.e. an annotated compound matched to a standard with
two orthogonal approaches), but when standards were not available, predicted retention times
were calculated by a previously validated model [78] (MSI confidence level 2, i.e. a putatively
annotated compound based on its exact mass determination). Published literature and path-
way/genome databases were considered to improve annotation in cases where isomers could
not be differentiated based on accurate mass and retention time. Metadata to support the iden-
tification of each metabolite is available in the IDEOM file for each study (S3 Table). Metabo-
lites included in the manuscript were manually annotated using authentic standards where
available. However, note that many of the metabolite names given in the Ideom file are generat-
ed automatically as the software provides a best match to database entries of the given mass
and formula. In the absence of additional information these must be considered as putatively-
annotated hits; the confidence score in the column adjacent to that hit serves as a guide to this.
Clearly it is beyond the scope of any study to provide authenticated annotations to many hun-
dreds of detected compounds, but the full datasets are included in the spirit of open
access data.
The mzmatch-ISO software [39] was used to extract all isotopologue abundances from all
identified and putative annotated metabolites. Raw data are available in the associated IDEOM
files (S3 Table) and chromatograms are in separate pdf files (S1–S2 Figs). Labelled metabolites
are given in S4 Table and S5 Table. Data analysis and interpretation was based on the 24 hour
time-point, at approximate steady state, unless otherwise stated.
NMR experiments
T. brucei bloodstream form cells (2.5 x107) were collected by centrifugation at 1,400 g for 10
min, washed with PBS containing 4 mM glucose and incubated for 5 h at 37°C in 2.5 ml of in-
cubation buffer (PBS supplemented with 5 g/l NaHCO3, pH 7.4) containing 4 mM glucose.
The integrity of the cells during the incubation was checked by microscopic observation. The
supernatant was collected and 50 μl of malate solution in D2O (20 mM) was added as internal
reference. 1H-NMR spectra were performed at 125.77 MHz on a Bruker DPX500 spectrometer
equipped with a 5 mm broadband probe head. Measurements were recorded at 25°C with an
ERETIC method. This method provides an electronically synthesized reference signal [79]. Ac-
quisition conditions were as follows: 90° flip angle, 5,000 Hz spectral width, 32 K memory size,
and 9.3 sec total recycle time. Measurements were performed with 256 scans for a total time
close to 40 min. Before each experiment, phase of ERETIC peak was precisely adjusted. Reso-
nances of obtained spectra were integrated and results were expressed relative to ERETIC
peak integration.
Inhibition of pepck gene expression by RNAi
Inhibition of pepck gene expression by RNAi in the 427 strain was performed by expression of
stem-loop “sense/anti-sense” RNAmolecules of the targeted sequences introduced in the
pHD1334 expression vector. First, the pLew-PEPCK-SAS plasmid was constructed to target a
481 bp fragment of the pepck gene (from position 22 bp to 503 bp). Briefly, a PCR-amplified
569 bp fragment, containing the antisense pepck sequence with restriction sites added to the
primers was inserted into the HindIII and BamHI restriction sites of the pLew100 plasmid.
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Then a PCR-amplified fragment containing the sense pepck sequence (505 bp) was inserted
upstream of the anti-sense sequence, usingHindIII and XhoI restriction sites (XhoI was intro-
duced at the 3’-extremity of the antisense PCR fragment). The resulting plasmid (pLew-
PEPCK-SAS) contains a sense and antisense version of the targeted gene fragment, separated
by a 52 bp fragment, under the control of the PARP promoter linked to a prokaryotic tetracy-
cline (Tet) operator. Then the PEPCK-SAS HindIII-BamHI cassette extracted from the pLew-
PEPCK-SAS plasmid was inserted inHindIII-BamHI digested pHD1334 vector. The RNAi-
PEPCK cell lines were produced by transfecting the 427 “double marker” (Hyg-Neo) mono-
morphic cell line with the pHD-PEPCK-SAS plasmid. Transfected cells were selected in
IMDMmedium containing, hygromycin (5 μg/ml), neomycin (2.5 μg/ml) and phleomycin
(2.5 μg/ml). Induction of double-stranded RNA expression was performed by addition of 10
μg/ml tetracycline.
Cloning and expression of the T. brucei transaldolase gene
A gene annotated as transaldolase in the T. brucei genome database Tb427.08.5600, was am-
plified with the following primers 5’-GCCATATGAATCAACTGGAGAGCCT-3’ and 5’-
GCCTCGAGTTACAAAAGTGTAGCGTGA-3’. The PCR product was first cloned into the
vector pGEM-T easy and then transferred to the pET28a(+) expression vector using the intro-
duced Nde1 and Xho1 restriction sites. The resultant plasmid was sequenced to confirm fideli-
ty and transformed into E. coli strain BL21 (DE3) for expression at 37°C or 4 hours after
induction with IPTG. Expressed protein was observed by SDS protein gel electrophoresis and
purified using Ni2+ chelate chromatography (Fig 2f). The ability of transaldolase to produce
octulose 8-phosphate was determined by mixing ribose 5-phosphate (5 mM) and fructose
6-phosphate (5 mM) in Tris-HCl (pH 7.2) and adding transaldolase (1.2 mg/mL) then incu-
bating at 20°C for 2 hrs. Alternatively the reaction was set up with no enzyme. The presence
of octulose 8-phosphate was determined by direct infusion of post-reaction mix into the
Exactive mass spectrometer (Fig 2f).
Western blot analyses
Total protein extracts of wild-type or mutant BSF of T. brucei (5 x106 cells) were size-fraction-
ated by SDS-PAGE (10%) and immunoblotted on Immobilon-P filters (Millipore) [80]. Immu-
nodetection was performed as described [81,82] using primary antibodies, rat anti-T. brucei
PEPCK (diluted 1:1000; gift from T. Seebeck, Bern, Switzerland), rabbit anti- T. brucei enolase
(diluted 1:1,000, gift from P. Michels, Edinburgh, UK) and mouse anti-HSP60 (diluted 1:10
000) [83], and as secondary antibodies, anti-rat, anti-rabbit or anti-mouse IgG conjugated to
horseradish peroxidase (BioRad, 1:5,000 dilution). Revelation was performed using the Super-
Signal West Pico Chemiluminescent Substrate as described by the manufacturer (Thermo Fish-
er Scientific). Alternatively, for quantitative analyses, revelation was performed using the
Luminata CrescendoWestern HRP Substrate (Millipore). Images were acquired and analyzed
with a KODAK Image Station 4000 MM and quantitative analyses were performed with the
KODAKMI application.
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